Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

People usually think of leopards in the savannas of Africa but in the Russian Far East, a rare subspecies has adapted to life in the temperate forests that make up the northern-most part of the ...

Last year, volunteers — many of whom work full- or part-time jobs — helped get more than 1,200 cats fixed. As for the adoptable cats, information is available from the group’s website, ...

Slow-acting insulin, such as NPH, does not lower blood sugars quickly. It takes several hours to work. Therefore, it's not an appropriate treatment when you urgently need to bring down your BGL.

Diabetes Care. 2025;48(Supplement_1):S27-S49. doi:10.2337/dc25-S002 National Library of Medicine: MedlinePlus. Hypoglycemia. Kaiser Permanente. Nutrition for older adults: care instructions. American ...